Histone Modifications in the Nervous System and Neuropsychiatric Disorders

Epigenetic Regulation in the Nervous System

Volumn , Issue , 2013, Pages 35-67

  Bridi, Morgan ^a   Abel, Ted ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882671673     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-391494-1.00002-1     Document Type: Chapter

References (197)

1. The Strategy of the Genes: A Discussion of Some Aspects of Theoretical Biology 1957, Allen & Unwin, London. C.H. Waddington (Ed.).
2. Waddington CH Canalization of development and the inheritance of acquired characters. Nature 1942, 150:563-565.
3. Holliday R, Pugh JE DNA modification mechanisms and gene activity during development. Science 1975, 187(4173):226-232.
4. Jaenisch R, Bird A Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003, 33(suppl):245-254.
5. Weaver ICG, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004, 7(8):847-854.
6. Weaver ICG, Meaney MJ, Szyf M Maternal care effects on the hippocampal transcriptome and anxiety- mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA 2006, 103(9):3480-3485.
7. Epigenetics 2007, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. C.D. Allis, T. Jenuwein, D. Reinberg, M.-L. Caparros (Eds.).
8. Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P Decoding the epigenetic language of neuronal plasticity. Neuron 2008, 60(6):961-974.
9. Richmond RK, Sargent DF, Richmond TJ, Luger K, Ma AW Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997, 389(6648):251-260.
10. Berger SL The complex language of chromatin regulation during transcription. Nature 2007, 447(7143):407-412.
11. Kouzarides T Chromatin modifications and their function. Cell 2007, 128(4):693-705.
12. Strahl BD, Allis CD The language of covalent histone modifications. Nature 2000, 403(6765):41-45.
13. Jenuwein T, Allis CD Translating the histone code. Science 2001, 293(5532):1074-1080.
14. Lee J-S, Smith E, Shilatifard A The language of histone crosstalk. Cell 2010, 142(5):682-685.
15. Martin C, Zhang Y Mechanisms of epigenetic inheritance. Curr Opin Cell Biol 2007, 19(3):266-272.
16. Ruthenburg AJ, Li H, Patel DJ, Allis CD Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 2007, 8(12):983-994.
17. Bannister AJ, Kouzarides T Regulation of chromatin by histone modifications. Cell Res 2011, 21(3):381-395.
18. Hebbes TR, Thorne AW A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J 1988, 7(5):1395-1402.
19. Berger SL Cell signaling and transcriptional regulation via histone phosphorylation. Cold Spring Harb Symp Quant Biol 2010, 75:23-26.
20. Zippo A, Serafini R, Rocchigiani M, Pennacchini S, Krepelova A, Oliviero S Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 2009, 138(6):1122-1136.
21. Gardner KE, Allis CD, Strahl BD Operating on chromatin, a colorful language where context matters. J Mol Biol 2011, 409(1):36-46.
22. Ng SS, Yue WW, Oppermann U, Klose RJ Dynamic protein methylation in chromatin biology. Cell Mol Life Sci 2009, 66(3):407-422.
23. Cuthbert GL, Daujat S, Snowden AW, et al. Histone deimination antagonizes arginine methylation. Cell 2004, 118(5):545-553.
24. Wang Y, Wysocka J, Sayegh J, et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 2004, 306(5694):279-283.
25. Raijmakers R, Zendman AJW, Egberts WV, et al. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J Mol Biol 2007, 367(4):1118-1129.
26. Sakabe K, Wang Z, Hart GW Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci USA 2010, 107(46):19915-19920.
27. Tan M, Luo H, Lee S, et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011, 146(6):1016-1028.
28. Alarcón JM, Malleret G, Touzani K, et al. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 2004, 42(6):947-959.
29. Akbarian S, Huang H-S Epigenetic regulation in human brain-focus on histone lysine methylation. Biol Psychiatry 2009, 65(3):198-203.
30. Bernstein BE, Kamal M, Lindblad-Toh K, et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005, 120(2):169-181.
31. Kurdistani SK, Tavazoie S, Grunstein M Mapping global histone acetylation patterns to gene expression. Cell 2004, 117(6):721-733.
32. Schübeler D, Macalpine DM, Scalzo D, et al. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev 2004, 18(11):1263-1271.
33. Dion MF, Altschuler SJ, Wu LF, Rando OJ Genomic characterization reveals a simple histone H4 acetylation code. Proc Natl Acad Sci USA 2005, 102(15):5501-5506.
34. Liu CL, Kaplan T, Kim M, et al. Single-nucleosome mapping of histone modifications in S. cerevisiae. PLoS Biol 2005, 3(10):e328.
35. Cui X-J, Li H, Liu G-Q, Wiley J Combinatorial patterns of histone modifications in saccharomyces cerevisiae. Yeast 2011, 28(9):683-691.
36. Wood MA, Hawk JD, Abel T Combinatorial chromatin modifications and memory storage: a code for memory?. Learn Mem 2006, 13(3):241-244.
37. Chwang WB, O'Riordan KJ, Levenson JM, Sweatt JD ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learn Mem 2006, 13(3):322-328.
38. Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, Allis CD Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell 2000, 5(6):905-915.
39. Brownell JE, Zhou J, Ranalli T, et al. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 1996, 84(6):843-851.
40. Lo W-S, Trievel RC, Rojas JR, et al. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell 2000, 5(6):917-926.
41. Sultan FA, Day JJ Epigenetic mechanisms in memory and synaptic function. Epigenomics 2011, 3(2):157-181.
42. Kamakaka RT, Biggins S Histone variants: deviants?. Genes Dev 2005, 19(3):295-310.
43. Kundu S, Peterson CL Role of chromatin states in transcriptional memory. Biochim Biophys Acta 2009, 1790(6):445-455.
44. Bredy TW, Lin Q, Wei W, Baker-Andresen D, Mattick JS MicroRNA regulation of neural plasticity and memory. Neurobiol Learn Mem 2011, 96(1):89-94.
45. Mercer TR, Dinger ME, Mariani J, Kosik KS, Mehler MF, Mattick JS Noncoding RNAs in long-term memory formation. Neuroscientist 2008, 14(5):434-445.
46. Majumdar A, Cesario WC, White-Grindley E, et al. Critical role of amyloid-like oligomers of drosophila orb2 in the persistence of memory. Cell 2012, 148(3):515-529.
47. Si K, Choi Y-B, White-Grindley E, Majumdar A, Kandel ER Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 2010, 140(3):421-435.
48. Si K, Lindquist S, Kandel ER A neuronal isoform of the aplysia CPEB has prion-like properties. Cell 2003, 115(7):879-891.
49. Miller CA, Sweatt JD Covalent modification of DNA regulates memory formation. Neuron 2007, 53(6):857-869.
50. Miller CA, Campbell SL, Sweatt JD DNA methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity. Neurobiol Learn Mem 2008, 89(4):599-603.
51. Francis D, Diorio J, Liu D, Meaney MJ Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 1999, 286(5442):1155-1158.
52. Ahmad K, Henikoff S The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell 2002, 9(6):1191-1200.
53. Goldberg AD, Banaszynski LA, Noh K-M, et al. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 2010, 140(5):678-691.
54. Henikoff S Labile H3.3 + H2A.Z nucleosomes mark "nucleosome-free regions". Nat Genet 2009, 41(8):865-866.
55. Henikoff S Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet 2008, 9(1):15-26.
56. Jin C, Felsenfeld G Nucleosome stability mediated by histone variants H3.3 and H2A.Z. Genes Dev 2007, 21(12):1519-1529.
57. Jin C, Zang C, Wei G, et al. H3.3/H2A.Z double variant-containing nucleosomes mark "nucleosome-free regions" of active promoters and other regulatory regions. Nat Genet 2009, 41(8):941-945.
58. Agranoff BW, Davis RE, Casola L, Lim R Actinomycin D blocks formation of memory of shock-avoidance in goldfish. Science 1967, 158(3808):1600-1601.
59. Flood JF, Rosenzweig MR, Bennett EL, Orme AE The influence of duration of protein synthesis inhibition on memory. Physiol Behav 1973, 10(3):555-562.
60. Huang YY, Nguyen PV, Abel T, Kandel ER Long-lasting forms of synaptic potentiation in the mammalian hippocampus. Learn Mem 1996, 3(2-3):74-85.
61. Nguyen PV, Abel T, Kandel ER Requirement of a critical period of transcription for induction of a late phase of LTP. Science 1994, 265(5175):1104-1107.
62. Peixoto L, Abel T The role of histone acetylation in memory formation and cognitive impairments. Neuropsychopharmacology 2012, 1-15.
63. Loebrich S, Nedivi E The function of activity-regulated genes in the nervous system. Physiol Rev 2009, 89(210):1079-1103.
64. Tischmeyer W, Grimm R Activation of immediate early genes and memory formation. Cell Mol Life Sci 1999, 55(4):564-574.
65. Schmitt M, Matthies H [Biochemical studies on histones of the central nervous system. III. Incorporation of [14C]-acetate into the histones of different rat brain regions during a learning experiment]. Acta Biol Med Ger 1979, 38(4):683-689.
66. Guan Z, Giustetto M, Lomvardas S, et al. Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 2002, 111(4):483-493.
67. Bourtchouladze R, Lidge R, Catapano R, et al. A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4. Proc Natl Acad Sci USA 2003, 100(18):10518-10522.
68. Korzus E, Rosenfeld MG, Mayford M CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 2004, 42(6):961-972.
69. Levenson JM, O'Riordan KJ, Brown KD, Trinh MA, Molfese DL, Sweatt JD Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 2004, 279(39):40545-40559.
70. Vecsey CG, Hawk JD, Lattal KM, et al. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci 2007, 27(23):6128-6140.
71. Duvarci S, Nader K, LeDoux JE De novo mRNA synthesis is required for both consolidation and reconsolidation of fear memories in the amygdala. Learn Mem 2008, 15(10):747-755.
72. Igaz LM, Vianna MRM, Medina JH, Izquierdo I Two time periods of hippocampal mRNA synthesis are required for memory consolidation of fear-motivated learning. J Neurosci 2002, 22(15):6781-6789.
73. Katche C, Bekinschtein P, Slipczuk L, et al. Delayed wave of c-Fos expression in the dorsal hippocampus involved specifically in persistence of long-term memory storage. Proc Natl Acad Sci USA 2010, 107(1):349-354.
74. Squire LR, Barondes SH Actinomycin-D: effects on memory at different times after training. Nature 1970, 225(5233):649-650.
75. Mahan AL, Mou L, Shah N, Hu J-H, Worley PF, Ressler KJ Epigenetic modulation of Homer1a transcription regulation in amygdala and hippocampus with Pavlovian fear conditioning. J Neurosci 2012, 32(13):4651-4659.
76. Peleg S, Sananbenesi F, Zovoilis A, et al. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010, 328(5979):753-756.
77. Bousiges O, Vasconcelos APD, Neidl R, et al. Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent transcriptional events in the rat hippocampus. Neuropsychopharmacology 2010, 35(13):2521-2537.
78. Engmann O, Hortobágyi T, Pidsley R, et al. Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. Brain 2011, 134(8):2408-2421.
79. Guan J-S, Haggarty SJ, Giacometti E, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009, 459(7243):55-60.
80. Chwang WB, Arthur JS, Schumacher A, Sweatt JD The nuclear kinase mitogen- and stress-activated protein kinase 1 regulates hippocampal chromatin remodeling in memory formation. J Neurosci 2007, 27(46):12732-12742.
81. Pittenger C, Huang YY, Paletzki RF, et al. Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory. Neuron 2002, 34(3):447-462.
82. Sakamoto K, Karelina K, Obrietan K CREB: a multifaceted regulator of neuronal plasticity and protection. J Neurochem 2011, 116(1):1-9.
83. Wood MA, Attner MA, Oliveira AMM, Brindle PK, Abel T A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes. Learn Mem 2006, 13(5):609-617.
84. Haettig J, Stefanko DP, Multani ML, Figueroa DX, McQuown SC, Wood MA HDAC inhibition modulates hippocampus-dependent long-term memory for object location in a CBP-dependent manner. Learn Mem 2011, 18(2):71-79.
85. Duclot F, Jacquet C, Gongora C, Maurice T Alteration of working memory but not in anxiety or stress response in p300/CBP associated factor (PCAF) histone acetylase knockout mice bred on a C57BL/6 background. Neurosci Lett 2010, 475(3):179-183.
86. Maurice T, Duclot F, Meunier J, et al. Altered memory capacities and response to stress in p300/CBP-associated factor (PCAF) histone acetylase knockout mice. Neuropsychopharmacology 2008, 33(7):1584-1602.
87. Oliveira AMM, Estévez MA, Hawk JD, Grimes S, Brindle PK, Abel T Subregion-specific p300 conditional knock-out mice exhibit long-term memory impairments. Learn Mem 2011, 18(3):161-169.
88. Oliveira AMM, Wood MA, McDonough CB, Abel T Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits. Learn Mem 2007, 14(9):564-572.
89. Ferland CL, Schrader LA Regulation of histone acetylation in the hippocampus of chronically stressed rats: a potential role of sirtuins. Neuroscience 2011, 174:104-114.
90. McQuown SC, Barrett RM, Matheos DP, et al. HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci 2011, 31(2):764-774.
91. Hawk JD, Florian C, Abel T Post-training intrahippocampal inhibition of class I histone deacetylases enhances long-term object-location memory. Learn Mem 2011, 18(6):367-370.
92. Sengupta N, Seto E Regulation of histone deacetylase activities. J Cell Biochem 2004, 93(1):57-67.
93. Jones PL, Sachs LM, Rouse N, Wade PA, Shi YB Multiple N-CoR complexes contain distinct histone deacetylases. J Biol Chem 2001, 276(12):8807-8811.
94. Bolden JE, Peart MJ, Johnstone RW Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006, 5(9):769-784.
95. Monsey MS, Ota KT, Akingbade IF, Hong ES, Schafe GE Epigenetic alterations are critical for fear memory consolidation and synaptic plasticity in the lateral amygdala. PLoS One 2011, 6(5):e19958.
96. Alberini CM The role of protein synthesis during the labile phases of memory: revisiting the skepticism. Neurobiol Learn Mem 2008, 89(3):234-246.
97. Debiec J, LeDoux JE, Nader K Cellular and systems reconsolidation in the hippocampus. Neuron 2002, 36(3):527-538.
98. Kaplan GB, Moore KA The use of cognitive enhancers in animal models of fear extinction. Pharmacol Biochem Behav 2011, 99(2):217-228.
99. Lattal KM, Radulovic J, Lukowiak K Extinction: does it or doesn't it? the requirement of altered gene activity and new protein synthesis. Biol Psychiatry 2006, 60(4):344-351.
100. Stafford JM, Lattal KM Is an epigenetic switch the key to persistent extinction?. Neurobiol Learn Mem 2011, 96(1):35-40.
101. Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 2007, 14(4):268-276.
102. Bredy TW, Barad M The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear. Learn Mem 2008, 15(1):39-45.
103. Lattal KM, Barrett RM, Wood MA Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav Neurosci 2007, 121(5):1125-1131.
104. Itzhak Y, Anderson KL, Kelley JB, Petkov M Histone acetylation rescues contextual fear conditioning in nNOS KO mice and accelerates extinction of cued fear conditioning in wild type mice. Neurobiol Learn Mem 2012, 97(4):409-417.
105. Simonini MV, Camargo LM, Dong E, et al. The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci USA 2006, 103(5):1587-1592.
106. Yeh S-H, Lin C-H, Gean P-W Acetylation of nuclear factor-kappaB in rat amygdala improves long-term but not short-term retention of fear memory. Mol Pharmacol 2004, 65(5):1286-1292.
107. Crosio C, Cermakian N, Allis CD, Sassone-Corsi P Light induces chromatin modification in cells of the mammalian circadian clock. Nat Neurosci 2000, 3(12):1241-1247.
108. Crosio C, Heitz E, Allis CD, Borrelli E, Sassone-Corsi P Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. J Cell Sci 2003, 116(24):4905-4914.
109. Bode AM, Dong Z Inducible covalent posttranslational modification of histone H3. Sci STKE 2005, 2005(281):re4.
110. Zippo A, De Robertis A, Serafini R, Oliviero S PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat Cell Biol 2007, 9(8):932-944.
111. Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt JD The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1998, 1(7):602-609.
112. Soloaga A, Thomson S, Wiggin GR, et al. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J 2003, 22(11):2788-2797.
113. Arthur JSC MSK activation and physiological roles. Front Biosci 2008, 13:5866-5879.
114. Brush MH, Guardiola A, Connor JH, Yao T-P, Shenolikar S Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. J Biol Chem 2004, 279(9):7685-7691.
115. Koshibu K, Gräff J, Beullens M, et al. Protein phosphatase 1 regulates the histone code for long-term memory. J Neurosci 2009, 29(41):13079-13089.
116. Thomson S, Clayton AL, Mahadevan LC Independent dynamic regulation of histone phosphorylation and acetylation during immediate-early gene induction. Mol Cell 2001, 8(6):1231-1241.
117. Banerjee T, Chakravarti D A peek into the complex realm of histone phosphorylation. Mol Cell Biol 2011, 31(24):4858-4873.
118. Gupta S, Kim SY, Artis S, et al. Histone methylation regulates memory formation. J Neurosci 2010, 30(10):3589-3599.
119. Jiang Y, Jakovcevski M, Bharadwaj R, et al. Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B. J Neurosci 2010, 30(21):7152-7167.
120. Ding N, Zhou H, Esteve P-O, et al. Mediator links epigenetic silencing of neuronal gene expression with X-linked mental retardation. Mol Cell 2008, 31(3):347-359.
121. Schaefer A, Sampath SC, Intrator A, et al. Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 2009, 64(5):678-691.
122. Gupta-Agarwal S, Franklin AV, DeRamus T, et al. G9a/GLP histone lysine dimethyltransferase complex activity in the hippocampus and the entorhinal cortex is required for gene activation and silencing during memory consolidation. J Neurosci 2012, 32(16):5440-5453.
123. Santos-Rebouças CB, Fintelman-Rodrigues N, Jensen LR, et al. A novel nonsense mutation in KDM5C/JARID1C gene causing intellectual disability, short stature and speech delay. Neurosci Lett 2011, 498(1):67-71.
124. Xia Z-B, Anderson M, Diaz MO, Zeleznik-Le NJ MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad Sci USA 2003, 100(14):8342-8347.
125. Yang L, Mei Q, Zielinska-Kwiatkowska A, et al. An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B. Biochem J 2003, 369:651-657.
126. Rubinstein JH, Taybi H Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child 1963, 105:588-608.
127. Blough RI, Petrij F, Dauwerse JG, et al. Variation in microdeletions of the cyclic AMP-responsive element-binding protein gene at chromosome band 16p13.3 in the Rubinstein-Taybi syndrome. Am J Med Genet 2000, 90(1):29-34.
128. Petrij F, Giles RH, Dauwerse HG, et al. Rubinstein-Taybi syndrome is caused by mutations in the transcriptional co-activataor CBP. Nature 1995, 376:348-351.
129. Roelfsema JH, White SJ, Ariyu Y, et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 2005, 76(4):572-580.
130. Tsai AC-H, Dossett CJ, Walton CS, et al. Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH. Eur J Hum Genet 2011, 19(1):43-49.
131. Viosca J, Lopez-Atalaya JP, Olivares R, Eckner R, Barco A Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology. Neurobiol Dis 2010, 37(1):186-194.
132. Tanaka Y, Naruse I, Maekawa T, Masuya H, Shiroishi T, Ishii S Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. Proc Natl Acad Sci USA 1997, 94(19):10215-10220.
133. Oike Y, Hata A, Mamiya T, et al. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum Mol Genet 1999, 8(3):387-396.
134. Parker D, Ferreri K, Nakajima T, et al. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol 1996, 16(2):694-703.
135. Tanaka Y, Naruse I, Hongo T, et al. Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein. Mech Dev 2000, 95(1-2):133-145.
136. Wood MA, Kaplan MP, Park A, et al. Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage. Learn Mem 2005, 12(2):111-119.
137. Kasper LH, Boussouar F, Ney PA, et al. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. Nature 2002, 419(6908):738-743.
138. Barrett RM, Malvaez M, Kramar E, et al. Hippocampal focal knockout of CBP affects specific histone modifications, long-term potentiation, and long-term memory. Neuropsychopharmacology 2011, 36(8):1545-1556.
139. Pokholok DK, Harbison CT, Levine S, et al. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 2005, 122(4):517-527.
140. Myers FA, Chong W, Evans DR, Thorne AW, Crane-Robinson C Acetylation of histone H2B mirrors that of H4 and H3 at the chicken beta-globin locus but not at housekeeping genes. J Biol Chem 2003, 278(38):36315-36322.
141. Ausió J, Levin DB, De Amorim GV, Bakker S, Macleod PM Syndromes of disordered chromatin remodeling. Clin Genet 2003, 64(2):83-95.
142. Gibbons RJ, Picketts DJ, Villard L, Higgs DR Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell 1995, 80(6):837-845.
143. McPherson EW, Clemens MM, Gibbons RJ, Higgs DR X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome: a new kindred with severe genital anomalies and mild hematologic expression. Am J Med Genet 1995, 55(3):302-306.
144. Gibbons RJ, Wada ÃT, Fisher CA, et al. Mutations in the chromatin-associated protein ATRX. Hum Mutat 2008, 29(6):796-802.
145. Lechner MS, Schultz DC, Negorev D, Maul GG, Rauscher FJ The mammalian heterochromatin protein 1 binds diverse nuclear proteins through a common motif that targets the chromoshadow domain. Biochem Biophys Res Commun 2005, 331(4):929-937.
146. Loyola A, Tagami H, Bonaldi T, et al. The HP1alpha-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin. EMBO Rep 2009, 10(7):769-775.
147. Gibbons R Alpha thalassaemia-mental retardation, X linked. Orphanet J Rare Dis 2006, 1:15.
148. Dhayalan A, Tamas R, Bock I, et al. The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9. Hum Mol Genet 2011, 20(11):2195-2203.
149. Iwase S, Xiang B, Ghosh S, et al. ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. Nat Struct Mol Biol 2011, 18(7):769-776.
150. Badens C, Lacoste C, Philip N, et al. Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome. Clin Genet 2006, 70(1):57-62.
151. Hyman SE, Malenka RC, Nestler EJ Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565-598.
152. Koob G, Kreek MJ Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 2007, 164(8):1149-1159.
153. Maze I, Nestler EJ The epigenetic landscape of addiction. Ann NY Acad Sci 2011, 1216:99-113.
154. Kumar A, Choi K-H, Renthal W, et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 2005, 48(2):303-314.
155. Bibb JA, Chen J, Taylor JR, et al. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 2001, 410(6826):376-380.
156. Grimm JW, Lu L, Hayashi T, Hope BT, Su T-P, Shaham Y Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 2003, 23(3):742-747.
157. Levine AA, Guan Z, Barco A, Xu S, Kandel ER, Schwartz JH CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci USA 2005, 102(52):19186-19191.
158. Malvaez M, Mhillaj E, Matheos DP, Palmery M, Wood MA CBP in the nucleus accumbens regulates cocaine-induced histone acetylation and is critical for cocaine-associated behaviors. J Neurosci 2011, 31(47):16941-16948.
159. Renthal W, Maze I, Krishnan V, et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 2007, 56(3):517-529.
160. Renthal W, Nestler EJ Chromatin regulation in drug addiction and depression. Dialogues Clin Neurosci 2009, 11(3):257-268.
161. Brami-Cherrier K, Valjent E, Hervé D, et al. Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice. J Neurosci 2005, 25(49):11444-11454.
162. Renthal W, Kumar A, Xiao G, et al. Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 2009, 62(3):335-348.
163. Maze I, Covington HE, Dietz DM, et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 2010, 327(5962):213-216.
164. Sawa A, Snyder SH Schizophrenia: diverse approaches to a complex disease. Science 2002, 296(5568):692-695.
165. Roth TL, Lubin FD, Sodhi M, Kleinman JE Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta 2009, 1790(9):869-877.
166. Akbarian S, Ruehl MG, Bliven E, et al. Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 2005, 62(8):829-840.
167. Akbarian S, Huang H-S Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 2006, 52(2):293-304.
168. Huang H-S, Matevossian A, Whittle C, et al. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci 2007, 27(42):11254-11262.
169. Sharma RP, Grayson DR, Gavin DP Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the national brain databank microarray collection. Schizophr Res 2008, 98(1-3):111-117.
170. Tremolizzo L, Doueiri M-S, Dong E, et al. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 2005, 57(5):500-509.
171. Citrome L Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?. Expert Rev Neurotherapeutics 2009, 9(1):55-71.
172. Casey DE, Daniel DG, Wassef AA, Tracy KA, Wozniak P, Sommerville KW Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 2003, 28(1):182-192.
173. Grayson DR, Kundakovic M, Sharma RP Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?. Mol Pharmacol 2010, 77(2):126-135.
174. Huang Y, Greene E, Murray Stewart T, et al. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc Natl Acad Sci USA 2007, 104(19):8023-8028.
175. Gavin DP, Akbarian S Epigenetic and post-transcriptional dysregulation of gene expression in schizophrenia and related disease. Neurobiol Dis 2012, 46(2):255-262.
176. Shirayama Y, Chen AC-H, Nakagawa S, Russell DS, Duman RS Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002, 22(8):3251-3261.
177. Monteggia LM, Barrot M, Powell CM, et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 2004, 101(29):10827-10832.
178. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006, 9(4):519-525.
179. Schroeder FA, Lin CL, Crusio WE, Akbarian S Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 2007, 62(1):55-64.
180. Gundersen BB, Blendy JA Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology 2009, 57(1):67-74.
181. Covington HE, Vialou VF, LaPlant Q, Ohnishi YN, Nestler EJ Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition. Neurosci Lett 2011, 493(3):122-126.
182. Covington HE, Maze I, LaPlant QC, et al. Antidepressant actions of histone deacetylase inhibitors. J Neurosci 2009, 29(37):11451-11460.
183. Guidotti A, Auta J, Davis JM, et al. Decrease in reelin and glutamic acid decarboxylase 67 (GAD 67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000, 57(11):1061-1069.
184. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 2002, 59(6):521-529.
185. Huang H-S, Akbarian S GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS One 2007, 2(8):e809.
186. Hobara T, Uchida S, Otsuki K, et al. Altered gene expression of histone deacetylases in mood disorder patients. J Psych Res 2010, 44(5):263-270.
187. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol 2001, 276(39):36734-36741.
188. Bach ME, Barad M, Son H, et al. Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc Natl Acad Sci USA 1999, 96(9):5280-5285.
189. Burke SN, Barnes CA Neural plasticity in the ageing brain. Nat Rev Neurosci 2006, 7(1):30-40.
190. Gallagher M, Rapp PR The use of animal models to study the effects of aging on cognition. Annu Rev Psychol 1997, 48:339-370.
191. Schimanski LA, Barnes CA Neural protein synthesis during aging: effects on plasticity and memory. Front Aging Neurosci 2010, 2(26):1-16.
192. Reolon GK, Maurmann N, Werenicz A, et al. Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats. Beh Brain Res 2011, 221(1):329-332.
193. Zeng Y, Tan M, Kohyama J, et al. Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging. J Neurosci 2011, 31(49):17800-17810.
194. Minichiello L TrkB signalling pathways in LTP and learning. Nat Rev Neurosci 2009, 10(12):850-860.
195. Stilling RM, Fischer A The role of histone acetylation in age-associated memory impairment and Alzheimer's disease. Neurobiol Learn Mem 2011, 96(1):19-26.
196. Alonso M, Vianna MRM, Izquierdo I, Medina JH Signaling mechanisms mediating BDNF modulation of memory formation in vivo in the hippocampus. Cell Mol Neurobiol 2002, 22(5-6):663-674.
197. Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 2002, 9(5):224-237.